ThinkstockIt is not that common that you hear about mergers in the $50 billion range. But what about when you hear of mergers in the $80 billion or $100 billion range? AstraZeneca…
Canaccord Genuity is one of the few firms that are willing to cover small-cap biotech and emerging pharma stocks. Sometimes the price target upside is off the charts as well. In case…
Jon C. Ogg thinkstockApril 7, 2014: Markets opened lower on Monday and were on a downhill slide all day long. Momentum stocks again had a terrible day. At the close of trading today the DJIA…
While the FDA has been far from a friend to MannKind over the past few years, the latest FDA panel backing may have given diabetes patients and investors some hope. That hope…
ThinkstockWhen the S&P 500 index rises more than 25% in a year, you have to figure that some of the largest U.S. corporations are doing pretty well. And you would be right.…
ThinkstockThe short interest data for the first two weeks of March is out, and the results among the top high-yield safe dividend stocks are mixed. The biggest changes took place in the…
Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large biotechnology stocks were not the lone rangers when it came to the…
thinkstockMarch 24, 2014: Markets opened slightly higher on Monday but soon took a turn south and spent most of the day solidly down. Biotechs, healthcare, discretionary, and tech stocks were all weaker…
thinkstockMarch 21, 2014: Markets opened higher on Friday but the Nasdaq sank quickly, bounced for a while, and finally settled solidly lower. It took the Dow and the S&P 500 until noon…
After a rocky week where the markets were concerned about everything from Russia, slowing Chinese growth and why Malaysia Airlines Flight 370 can’t be found, some investors have started to move out of volatile…
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis, of the top health care stocks to buy now. Investors concerned about…
Wikimedia CommonsShares of drug maker Pfizer Inc. (NYSE: PFE) were halted Wednesday afternoon at $32.29, down about 0.4% from the opening price. The company announced that its patent infringement case against a…
Paul Ausick ThinkstockThe short interest data for the final two weeks of February is out, and the results are somewhat surprising when it comes to the top high-yield safe dividends out there. Some of…
In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the Cowen 2014 Healthcare Conference by large cap pharmaceutical companies concerning upcoming events…
thinkstockMarch 6, 2014: Markets opened higher on Thursday after an encouraging report on new claims for jobless benefits, an improvement (for workers) in unit labor costs, and a decline in factory orders.…
